- Home
- AIFF vs PLUR Comparison
AIFF vs PLUR Comparison
Compare AIFF & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIFF
- PLUR
- Stock Information
- Founded
- AIFF 2006
- PLUR 2001
- Country
- AIFF Canada
- PLUR Israel
- Employees
- AIFF N/A
- PLUR N/A
- Industry
- AIFF
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AIFF
- PLUR Health Care
- Exchange
- AIFF NYSE
- PLUR Nasdaq
- Market Cap
- AIFF 26.6M
- PLUR 24.9M
- IPO Year
- AIFF N/A
- PLUR N/A
- Fundamental
- Price
- AIFF $7.79
- PLUR $4.33
- Analyst Decision
- AIFF
- PLUR
- Analyst Count
- AIFF 0
- PLUR 0
- Target Price
- AIFF N/A
- PLUR N/A
- AVG Volume (30 Days)
- AIFF 18.1M
- PLUR 6.8K
- Earning Date
- AIFF 03-04-2025
- PLUR 02-11-2025
- Dividend Yield
- AIFF N/A
- PLUR N/A
- EPS Growth
- AIFF N/A
- PLUR N/A
- EPS
- AIFF N/A
- PLUR N/A
- Revenue
- AIFF $74,000.00
- PLUR $678,000.00
- Revenue This Year
- AIFF N/A
- PLUR N/A
- Revenue Next Year
- AIFF N/A
- PLUR N/A
- P/E Ratio
- AIFF N/A
- PLUR N/A
- Revenue Growth
- AIFF N/A
- PLUR 89.92
- 52 Week Low
- AIFF $1.86
- PLUR $4.07
- 52 Week High
- AIFF $17.20
- PLUR $8.48
- Technical
- Relative Strength Index (RSI)
- AIFF 55.76
- PLUR 45.34
- Support Level
- AIFF $7.11
- PLUR $4.45
- Resistance Level
- AIFF $17.20
- PLUR $4.78
- Average True Range (ATR)
- AIFF 2.04
- PLUR 0.20
- MACD
- AIFF 0.15
- PLUR 0.01
- Stochastic Oscillator
- AIFF 33.45
- PLUR 17.86
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing innovative neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support better outcomes for people suffering from mental illnesses and cognitive disorders.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.